U.S. Markets closed

Here's What Kelfred Holdings Limited's (HKG:1134) ROCE Can Tell Us

Simply Wall St

Today we are going to look at Kelfred Holdings Limited (HKG:1134) to see whether it might be an attractive investment prospect. To be precise, we'll consider its Return On Capital Employed (ROCE), as that will inform our view of the quality of the business.

First of all, we'll work out how to calculate ROCE. Then we'll compare its ROCE to similar companies. And finally, we'll look at how its current liabilities are impacting its ROCE.

What is Return On Capital Employed (ROCE)?

ROCE measures the 'return' (pre-tax profit) a company generates from capital employed in its business. In general, businesses with a higher ROCE are usually better quality. Overall, it is a valuable metric that has its flaws. Renowned investment researcher Michael Mauboussin has suggested that a high ROCE can indicate that 'one dollar invested in the company generates value of more than one dollar'.

How Do You Calculate Return On Capital Employed?

The formula for calculating the return on capital employed is:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

Or for Kelfred Holdings:

0.41 = HK$45m ÷ (HK$221m - HK$112m) (Based on the trailing twelve months to June 2019.)

Therefore, Kelfred Holdings has an ROCE of 41%.

Check out our latest analysis for Kelfred Holdings

Does Kelfred Holdings Have A Good ROCE?

ROCE is commonly used for comparing the performance of similar businesses. Using our data, we find that Kelfred Holdings's ROCE is meaningfully better than the 11% average in the Medical Equipment industry. We consider this a positive sign, because it suggests it uses capital more efficiently than similar companies. Putting aside its position relative to its industry for now, in absolute terms, Kelfred Holdings's ROCE is currently very good.

You can see in the image below how Kelfred Holdings's ROCE compares to its industry. Click to see more on past growth.

SEHK:1134 Past Revenue and Net Income, February 12th 2020

When considering this metric, keep in mind that it is backwards looking, and not necessarily predictive. Companies in cyclical industries can be difficult to understand using ROCE, as returns typically look high during boom times, and low during busts. This is because ROCE only looks at one year, instead of considering returns across a whole cycle. How cyclical is Kelfred Holdings? You can see for yourself by looking at this free graph of past earnings, revenue and cash flow.

What Are Current Liabilities, And How Do They Affect Kelfred Holdings's ROCE?

Current liabilities are short term bills and invoices that need to be paid in 12 months or less. The ROCE equation subtracts current liabilities from capital employed, so a company with a lot of current liabilities appears to have less capital employed, and a higher ROCE than otherwise. To counter this, investors can check if a company has high current liabilities relative to total assets.

Kelfred Holdings has current liabilities of HK$112m and total assets of HK$221m. Therefore its current liabilities are equivalent to approximately 51% of its total assets. Kelfred Holdings boasts an attractive ROCE, even after considering the boost from high current liabilities.

What We Can Learn From Kelfred Holdings's ROCE

So to us, the company is potentially worth investigating further. Kelfred Holdings looks strong on this analysis, but there are plenty of other companies that could be a good opportunity . Here is a free list of companies growing earnings rapidly.

If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.